Paula Dakin

10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

Henry G. Bone, Rachel B. Wagman, Maria Luisa Brandi et al. · The Lancet Diabetes & Endocrinology · 2017 · 916 citations · Full text

Bone Disease, Denosumab Treatment, Bone Health +9

The Efficacy, Tolerability, and Joint Safety of Fasinumab in Osteoarthritis Pain: A Phase IIb/III Double‐Blind, Placebo‐Controlled, Randomized Clinical Trial

Paula Dakin, Stephen J. DiMartino, Haitao Gao et al. · Arthritis & Rheumatology · 2019 · 89 citations · Full text

Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study

Stuart L. Silverman, Ethel S. Siris, David L. Kendler et al. · Osteoporosis International · 2014 · 56 citations · Full text

Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials

Surya P. Bhatt, Klaus F. Rabe, Nicola A. Hanania et al. · The Lancet Respiratory Medicine · 2025 · 45 citations · Full text

Advanced Lung Disease, Clinical Trials, Type 2 +4

Efficacy and safety of fasinumab in patients with chronic low back pain: a phase II/III randomised clinical trial

Paula Dakin, Alan Kivitz, Joseph Gimbel et al. · Annals of the Rheumatic Diseases · 2020 · 36 citations · Full text